$AVEO AVEO PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in AVEO PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AVEO PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in AVEO PHARMACEUTICALS, INC. for free.
CIK Number: 0001325879
IRS Number: 043581650
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AVEO
Company Address: 30 WINTER STREET BOSTON 02108
Phone number: 6172995000
Former name: GenPath Pharmaceuticals, Inc.
Former name: AVEO PHARMACEUTICALS INC, date of change: 2005-05-03
Market Capitalization: $45.51M
Prev close: $0.61
Average Daily Volume: 300,211
Days Low: $0.60
Year Low: $0.54
Year High: $1.23
AVEO PHARMACEUTICALS, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2021 | AVEO | AVEO PHARMACEUTICA ... | Cullen Kevin Joseph | Director | Option Exercise | A | 6.30 | 25,000 | 157,500 | 25,000 | |
Apr 27 2021 | AVEO | AVEO PHARMACEUTICA ... | Cullen Kevin Joseph | Director | Option Exercise | A | 6.30 | 25,000 | 157,500 | 25,000 | |
Apr 16 2021 | AVEO | AVEO PHARMACEUTICA ... | BAILEY MICHAEL P | President & CEO | Option Exercise | A | 9.12 | 275,000 | 2,508,000 | 275,000 | |
Apr 16 2021 | AVEO | AVEO PHARMACEUTICA ... | Needle Michael N | Chief Medical Offic ... | Option Exercise | A | 9.12 | 100,000 | 912,000 | 100,000 | |
Apr 16 2021 | AVEO | AVEO PHARMACEUTICA ... | Lucera Erick | Chief Financial Off ... | Option Exercise | A | 9.12 | 100,000 | 912,000 | 100,000 | |
Apr 14 2021 | AVEO | AVEO PHARMACEUTICA ... | Epperly Corinne | Director | Option Exercise | A | 6.46 | 15,000 | 96,900 | 15,000 | |
Jan 08 2021 | AVEO | AVEO PHARMACEUTICA ... | Epperly Corinne | Director | Option Exercise | A | 6.31 | 10,000 | 63,100 | 10,000 | |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | YOUNG ROBERT C | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | Mayes, Gregory T. | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | Spring Scarlett | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | BATE KENNETH | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 30 2020 | AVEO | AVEO PHARMACEUTICA ... | EVNIN ANTHONY B | Director | Option Exercise | A | 7.52 | 4,000 | 30,080 | 4,000 | |
Jun 22 2020 | AVEO | AVEO PHARMACEUTICA ... | Sonsini Peter W. | 10% Owner | Buy | P | 5.25 | 1,428,571 | 7,499,998 | 3,952,958 | 2.5 M to 4 M (+56.59 %) |
Jun 22 2020 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 5.25 | 1,428,571 | 7,499,998 | 3,952,958 | 2.5 M to 4 M (+56.59 %) |
Jun 22 2020 | AVEO | AVEO PHARMACEUTICA ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 5.25 | 1,428,571 | 7,499,998 | 3,952,958 | 2.5 M to 4 M (+56.59 %) |